Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health
Healthcare Communications | Pharmaceutical Executive | Medical Executive | Tech PR | Scientific Executive
Latest Jobs

High Wycombe
6 March 2015 14:35

Oxford and Hertfordshire
6 March 2015 14:17

6 March 2015 14:05

Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
I just thought I would drop you a note with a BIG THANK YOU for all your help over the last few months. I have been very impressed with Zenoap's professionalism.
Paula, 2011

Integrated DNA Technologies launches new xGen sequencing panels

31 March 2014 16:11 in Scientific Company News

Integrated DNA Technologies launches new xGen sequencing panelsIntegrated DNA Technologies is expanding its next-generation sequencing portfolio with the addition of the new xGen Inherited Disease and Pan-Cancer Panels.

The first of these new offerings was introduced at a recent American College of Medical Genetics and Genomics event and was designed in collaboration with Emory Genetics Laboratory. It combines the ease of whole exome sequencing with the low cost of panels.

Meanwhile, the Pan-Cancer Panel will be launched at the American Association for Cancer Research annual meeting next week and targets coding regions in 127 significantly mutated genes across 12 tumour types.

The target enrichment technology featured in the xGen products has made next-generation sequencing more accessible by enabling users to focus efforts on specific regions of the genome, proving more cost-effective and reliable than whole genome sequencing.

Ibrahim Jivanjee, product manager for next-generation sequencing at Integrated DNA Technologies, said: "A rapidly advancing area, next-generation sequencing is key to the development of personalised medicine, and these two new panels will aid us in supporting advancements in human health and clinical research."

This comes after the firm introduced its xGen Universal Blocking Oligos at the end of last year.ADNFCR-8000103-ID-801708428-ADNFCR

Other news stories from 31/03/2014

Recent news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Axonn News Agency

© Copyright 2015 Zenopa Ltd